This inventor holds 1 USPTO granted patent. Top assignee: Merck Patent Gmbh. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: Ralph Guenther: Innovator in Antibody Production
Introduction
Ralph Guenther is a notable inventor based in Griesheim, Germany. He has made significant contributions to the field of biotechnology, particularly in the production of antibodies. His innovative methods have the potential to enhance the efficiency of antibody production, which is crucial for various applications in research and medicine.
Latest Patents
Ralph Guenther holds a patent for a method of producing secretable antibodies by expression in Saccharomyces cerevisiae. This invention relates to a method for the production and non-covalent surface display of antibodies and derived fragments, as well as molecule libraries based on the surface of cells. The non-covalent manner of surface display allows for the selection of specific variants through high throughput screening. This process enables the subsequent switchable secretion of the selected binding molecule into the culture supernatant for biochemical characterization.
Career Highlights
Ralph Guenther is currently associated with Merck Patent GmbH, where he continues to work on innovative solutions in biotechnology. His expertise in antibody production has positioned him as a valuable asset in his field. With a focus on practical applications, Guenther's work contributes to advancements in therapeutic and diagnostic technologies.
Collaborations
Ralph Guenther collaborates with talented individuals such as Bjoern Hock and Stefan Becker. These partnerships enhance the research and development efforts at Merck Patent GmbH, fostering an environment of innovation and creativity.
Conclusion
Ralph Guenther's contributions to the field of antibody production exemplify the impact of innovative thinking in biotechnology. His patented methods and collaborative efforts continue to drive advancements in the industry.